galantamine and Attention Deficit Disorder with Hyperactivity

galantamine has been researched along with Attention Deficit Disorder with Hyperactivity in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arias, HR; Manetti, D; Romanelli, MN; Wadenberg, MG	1
Aleardi, M; Biederman, J; Dougherty, M; Faraone, S; Hammerness, P; Harpold, T; Mick, E; Spencer, T; Surman, C	1
Craven-Thuss, B; Nicolson, R; Smith, J	1

Trials

1 trial(s) available for galantamine and Attention Deficit Disorder with Hyperactivity

Article	Year
A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:2 Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Cholinesterase Inhibitors; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Patient Dropouts; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Treatment Outcome	2006

Article

Year

A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study.

Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:2

Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Cholinesterase Inhibitors; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Patient Dropouts; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Treatment Outcome

2006

Other Studies

2 other study(ies) available for galantamine and Attention Deficit Disorder with Hyperactivity

Article	Year
Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat. Behavioural brain research, 2017, 08-30, Volume: 333 Topics: Acrylamides; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Cognition Disorders; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Furans; Galantamine; Male; Phencyclidine; Rats; Rats, Wistar; Statistics, Nonparametric; Time Factors	2017
A prospective, open-label trial of galantamine in autistic disorder. Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5 Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Behavior Disorders; Child, Preschool; Cholinesterase Inhibitors; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Galantamine; Humans; Irritable Mood; Male; Personality Assessment; Prospective Studies; Social Behavior	2006

Article

Year

Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat.

Behavioural brain research, 2017, 08-30, Volume: 333

Topics: Acrylamides; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Cognition Disorders; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Furans; Galantamine; Male; Phencyclidine; Rats; Rats, Wistar; Statistics, Nonparametric; Time Factors

2017

A prospective, open-label trial of galantamine in autistic disorder.

Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5

Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Behavior Disorders; Child, Preschool; Cholinesterase Inhibitors; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Galantamine; Humans; Irritable Mood; Male; Personality Assessment; Prospective Studies; Social Behavior

2006